Chemed Corporation (CHE) Tops Q2 EPS by 4c

Go back to Chemed Corporation (CHE) Tops Q2 EPS by 4c

Chemed (CHE) PT Raised to $340 at Oppenheimer

July 27, 2018 9:37 AM EDT

Oppenheimer raised its price target on Chemed (NYSE: CHE) to $340.00 (from $315.00) while maintaining a Outperform rating.

Analyst Michael Wiederhorn commented, "CHE reported 2Q:18 adj. EPS of $2.81 (GAAP: $3.27) vs. OPCO/Street ests. of $2.68/$2.77. Adj. results exclude the normal items (OIG/stock... More